Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Cash from Financing Activities (2022 - 2025)

Sagimet Biosciences' Cash from Financing Activities history spans 4 years, with the latest figure at $274000.0 for Q3 2025.

  • Quarterly Cash from Financing Activities changed N/A to $274000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $274000.0 through Dec 2025, down 99.74% year-over-year, with the annual reading at $275000.0 for FY2025, 99.74% down from the prior year.
  • Cash from Financing Activities came in at $274000.0 for Q3 2025, up from -$27000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $104.8 million in Q1 2024 to a low of -$910000.0 in Q2 2023.
  • The 4-year median for Cash from Financing Activities is -$27000.0 (2024), against an average of $27.3 million.
  • The largest YoY upside for Cash from Financing Activities was 77192.65% in 2024 against a maximum downside of 97.03% in 2024.
  • Sagimet Biosciences' Cash from Financing Activities stood at -$55000.0 in 2022, then soared by 158669.09% to $87.2 million in 2023, then tumbled by 100.03% to -$27000.0 in 2024, then surged by 1114.81% to $274000.0 in 2025.
  • Per Business Quant, the three most recent readings for SGMT's Cash from Financing Activities are $274000.0 (Q3 2025), -$27000.0 (Q2 2024), and $104.8 million (Q1 2024).